Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chris David Ridd Insider Profile
4 Followers
Chris David Ridd, Director at MedAdvisor Limited, holds 184.21K shares in MedAdvisor Limited (Ticker: AU:MDR). Most recently, Chris David Ridd Bought AU$184,210 shares of MedAdvisor Limited on Dec 22, 2020 for an estimated value of 70.00K.
Chris David Ridd has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Chris David Ridd's holdings
Insider Roles
Director
Roles that Chris David Ridd holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Chris David Ridd
Chris David Ridd's Trading History
List of latest transactions for each holding click on a transaction to see Chris David Ridd's performance on stock
You May Also Like
Chris David Ridd insider profile FAQ
What is the percentage of profitable transactions made by Chris David Ridd?
The percentage of profitable transactions made by Chris David Ridd is ―.
What is the average return per transaction made by Chris David Ridd?
The average return per transaction made by Chris David Ridd is ―.
What stocks does Chris David Ridd hold?
Chris David Ridd holds: AU:MDR stocks.
What was Chris David Ridd’s latest transaction?
Chris David Ridd latest transaction was an Informative Buy of AU$70.00K.
What was Chris David Ridd's most profitable transaction?
Chris David Ridd’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Chris David Ridd's role in MedAdvisor Limited?
Chris David Ridd's role in MedAdvisor Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.